-
1 . Academic Journal
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study
- 저자
- by PIGNOT, Géraldine; FENDLER, Jean Philippe; GUY, Laurent; VERHOEST, Grégory; MOTTET, Nicolas, et al.
- 소스
- In The Lancet Oncology February 2024 25(2):255-264